Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
09/04/2026 12:14
April 9 (Reuters) - Medicenna Therapeutics Corp MDNA.TO: MEDICENNA THERAPEUTICS APPOINTS DR. NAGEATTE IBRAHIM AS CHIEF MEDICAL OFFICER Source text: ID:nGNXcQC1r Further company coverage: MDNA.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results